Pharmacy Medical News about Neoplasms Pain Fentanyl

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial
Current Medical Research and Opinion, 10/08/09

Mercadante S et al. – In this open–label, randomised, crossover trial, significantly more patients attained faster ‘meaningful’ pain relief with intranasal fentanyl spray (INFS) than oral transmucosal fentanyl citrate (OTFC), and more patients preferred INFS to OTFC.

<< Previous
Transplacental pharmacokinetics of glyburide, rhodamine 123 and...

Next >>
Monoacyl glycerol lipase limits the duration of...

Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain
Current Medical Research and Opinion, 10/13/09 Relevance Score: 81%

The Role of Fentanyl in Cancer-Related Pain
Journal of Palliative Medicine, 10/07/09 Relevance Score: 81%

The Use of Transdermal Fentanyl in Cancer Pain: A Compliance Study of Outpatients in Taiwan
American Journal of Hospice and Palliative Medicine, 10/05/09 Relevance Score: 80%

Core Aspects of Satisfaction with Pain Management: Cancer Patients' Perspectives
Journal of Pain and Symptom Management, 11/02/09 Relevance Score: 68%

Effect Of Microcurrent Skin Patch On The Epidural Fentanyl Requirements For Post Operative Pain Relief Of Total Hip Arthroplasty
Middle East Journal of Anesthesiology, 10/06/09 Relevance Score: 68%